{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:21:30Z","timestamp":1793715690685,"version":"4.6.1"},"reference-count":36,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"vor","delay-in-days":53,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>This study was conducted to describe the incidence of diabetes following pancreatic disease, assess how these patients are classified by clinicians, and compare clinical characteristics with type 1 and type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Primary care records in England (n = 2,360,631) were searched for incident cases of adult-onset diabetes between 1 January 2005 and 31 March 2016. We examined demographics, diabetes classification, glycemic control, and insulin use in those with and without pancreatic disease (subcategorized into acute pancreatitis or chronic pancreatic disease) before diabetes diagnosis. Regression analysis was used to control for baseline potential risk factors for poor glycemic control (HbA1c \u22657% [53 mmol\/mol]) and insulin requirement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>We identified 31,789 new diagnoses of adult-onset diabetes. Diabetes following pancreatic disease (2.59 [95% CI 2.38\u20132.81] per 100,000 person-years) was more common than type 1 diabetes (1.64 [1.47\u20131.82]; P &amp;lt; 0.001). The 559 cases of diabetes following pancreatic disease were mostly classified by clinicians as type 2 diabetes (87.8%) and uncommonly as diabetes of the exocrine pancreas (2.7%). Diabetes following pancreatic disease was diagnosed at a median age of 59 years and BMI of 29.2 kg\/m2. Diabetes following pancreatic disease was associated with poor glycemic control (adjusted odds ratio, 1.7 [1.3\u20132.2]; P &amp;lt; 0.001) compared with type 2 diabetes. Insulin use within 5 years was 4.1% (3.8\u20134.4) with type 2 diabetes, 20.9% (14.6\u201328.9) with diabetes following acute pancreatitis, and 45.8% (34.2\u201357.9) with diabetes following chronic pancreatic disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Diabetes of the exocrine pancreas is frequently labeled type 2 diabetes but has worse glycemic control and a markedly greater requirement for insulin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc17-0542","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T20:40:18Z","timestamp":1504212018000},"page":"1486-1493","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":255,"title":["Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study"],"prefix":"10.2337","volume":"40","author":[{"given":"Chris","family":"Woodmansey","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"McGovern","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"McCullough","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."},{"name":"The Centre for Diabetes, Endocrinology and Research (CEDAR), Royal Surrey County Hospital, Guildford, Surrey, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Whyte","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."},{"name":"The Centre for Diabetes, Endocrinology and Research (CEDAR), Royal Surrey County Hospital, Guildford, Surrey, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Munro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Correa","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers A.C.","family":"Gatenby","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."},{"name":"Regional Oesophagogastric Unit\/Gastrointestinal Surgery, Royal Surrey County Hospital, Guildford, Surrey, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."},{"name":"Division of Healthcare Delivery Science\/Center for Healthcare Innovation and Delivery Science (CHIDS), Department of Population Health, New York University, Langone Medical Centre, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-2641","authenticated-orcid":false,"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Surrey, Guildford, Surrey, U.K."},{"name":"Royal College of General Practitioners Research and Surveillance Centre, London, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"2022031301500384100_B1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/dmrr.2260","article-title":"Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c)","volume":"28","author":"Ewald","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031301500384100_B2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2022031301500384100_B3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000201029","article-title":"Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease","volume":"54","author":"Lankisch","year":"1993","journal-title":"Digestion"},{"key":"2022031301500384100_B4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pan.2017.06.007","article-title":"Diabetes of the exocrine pancreas: American Diabetes Association-compliant lexicon","volume":"17","author":"Petrov","year":"2017","journal-title":"Pancreatology"},{"key":"2022031301500384100_B5","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s10620-012-2086-7","article-title":"\u03b2-Cell dysfunction in chronic pancreatitis","volume":"57","author":"Sasikala","year":"2012","journal-title":"Dig Dis Sci"},{"key":"2022031301500384100_B6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.dld.2006.01.022","article-title":"Diabetic control after total pancreatectomy","volume":"38","author":"Jethwa","year":"2006","journal-title":"Dig Liver Dis"},{"key":"2022031301500384100_B7","first-page":"3566","article-title":"Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis","volume":"81","author":"Brunicardi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031301500384100_B8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000329188","article-title":"Pancreatogenic diabetes: special considerations for management","volume":"11","author":"Cui","year":"2011","journal-title":"Pancreatology"},{"key":"2022031301500384100_B9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.regpep.2010.05.011","article-title":"Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis","volume":"164","author":"Knop","year":"2010","journal-title":"Regul Pept"},{"key":"2022031301500384100_B10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12325-014-0100-5","article-title":"Incorporating incretin-based therapies into clinical practice for patients with type 2 diabetes","volume":"31","author":"Tibaldi","year":"2014","journal-title":"Adv Ther"},{"key":"2022031301500384100_B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejcn.2016.127","article-title":"The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis","volume":"71","author":"Duggan","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"2022031301500384100_B12","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.3748\/wjg.v20.i33.11467","article-title":"Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century","volume":"20","author":"Trang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2022031301500384100_B13","first-page":"1991","article-title":"Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease","volume":"32","author":"Klapdor","year":"2012","journal-title":"Anticancer Res"},{"key":"2022031301500384100_B14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/0016-5085(90)91093-L","article-title":"Diabetic retinopathy in chronic pancreatitis","volume":"98","author":"Gullo","year":"1990","journal-title":"Gastroenterology"},{"key":"2022031301500384100_B15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11154-008-9101-5","article-title":"Beta-cell failure as a complication of diabetes","volume":"9","author":"Chang-Chen","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"2022031301500384100_B16","doi-asserted-by":"crossref","first-page":"e010210","DOI":"10.1136\/bmjopen-2015-010210","article-title":"Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study","volume":"6","author":"Sharma","year":"2016","journal-title":"BMJ Open"},{"key":"2022031301500384100_B17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/gutjnl-2013-305062","article-title":"Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis","volume":"63","author":"Das","year":"2014","journal-title":"Gut"},{"key":"2022031301500384100_B18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.dld.2016.12.010","article-title":"Age- and sex-specific prevalence of diabetes associated with diseases of the exocrine pancreas: a population-based study","volume":"49","author":"Pendharkar","year":"2017","journal-title":"Dig Liver Dis"},{"key":"2022031301500384100_B19","doi-asserted-by":"crossref","first-page":"e011092","DOI":"10.1136\/bmjopen-2016-011092","article-title":"Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile","volume":"6","author":"Correa","year":"2016","journal-title":"BMJ Open"},{"key":"2022031301500384100_B20","first-page":"65","article-title":"Codes, classifications, terminologies and nomenclatures: definition, development and application in practice","volume":"13","author":"de Lusignan","year":"2005","journal-title":"Inform Prim Care"},{"key":"2022031301500384100_B21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2807\/esm.11.10.00651-en","article-title":"Surveillance of influenza-like illness in England and Wales during 1966-2006","volume":"11","author":"Elliot","year":"2006","journal-title":"Euro Surveill"},{"key":"2022031301500384100_B22","unstructured":"National Institute for Health and Clinical Excellence. Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17] [Internet], updated July 2016. Available from https:\/\/www.nice.org.uk\/guidance\/ng17. Accessed 7 July 2017"},{"key":"2022031301500384100_B23","unstructured":"National Institute for Health and Clinical Excellence. Type 2 diabetes in adults: management. NICE guideline [NG28] [Internet], updated May 2017. Available from https:\/\/www.nice.org.uk\/guidance\/ng28. Accessed 7 July 2017"},{"key":"2022031301500384100_B24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031301500384100_B25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2307\/2981577","article-title":"Tests of significance for 2 x 2 contingency tables","volume":"147","author":"Yates","year":"1984","journal-title":"J R Stat Soc [Ser A]"},{"key":"2022031301500384100_B26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.2517-6161.1958.tb00292.x","article-title":"The regression analysis of binary sequences","volume":"20","author":"Cox","year":"1958","journal-title":"J R Stat Soc B"},{"key":"2022031301500384100_B27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2022031301500384100_B28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"2022031301500384100_B29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"2022031301500384100_B30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/oxfordjournals.aje.a113113","article-title":"Selection bias in epidemiologic studies","volume":"113","author":"Kleinbaum","year":"1981","journal-title":"Am J Epidemiol"},{"key":"2022031301500384100_B31","first-page":"55","article-title":"Ethnic and geographic variations in the incidence of pancreatitis and post-pancreatitis diabetes mellitus in New Zealand: a nationwide population-based study","volume":"130","author":"Pendharkar","year":"2017","journal-title":"N Z Med J"},{"key":"2022031301500384100_B32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pan.2013.05.002","article-title":"Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012","volume":"13","author":"Rickels","year":"2013","journal-title":"Pancreatology"},{"key":"2022031301500384100_B33","first-page":"1707","article-title":"Endocrine pancreatic function in patients after acute pancreatitis","volume":"49","author":"Malecka-Panas","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"2022031301500384100_B34","first-page":"1","article-title":"Glucose tolerance and secretion of insulin in chronic pancreatitis","volume":"131","author":"Perusicov\u00e1","year":"1989","journal-title":"Acta Univ Carol Med Monogr"},{"key":"2022031301500384100_B35","doi-asserted-by":"crossref","first-page":"G50","DOI":"10.1152\/ajpgi.00074.2016","article-title":"Relationship between pancreatic hormones and glucose metabolism: a cross-sectional study in patients after acute pancreatitis","volume":"311","author":"Pendharkar","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022031301500384100_B36","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.pan.2016.06.661","article-title":"Interleukin-6 is associated with chronic hyperglycemia and insulin resistance in patients after acute pancreatitis","volume":"16","author":"Gillies","year":"2016","journal-title":"Pancreatology"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/40\/11\/1486\/551843\/dc170542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/40\/11\/1486\/551843\/dc170542.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T12:43:54Z","timestamp":1719405834000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/40\/11\/1486\/36928\/Incidence-Demographics-and-Clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,8,31]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc17-0542","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]}}}